Healthtech Startups

Praia Health offers a platform for health systems to unify patient portals, digital tools, and AI initiatives into personalized patient journeys with single sign-on and third-party integrations. It aims to improve patient engagement, portal adoption, and campaign conversion while reducing operating costs and tech debt.

3 investors

3 investors

Prax Health provides software and services to help healthcare providers start, run, and grow independent practices. The platform simplifies compliance, operations, and financial management for clinicians seeking flexible work arrangements outside traditional healthcare systems.

3 investors

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy. Its portfolio uses both small molecule (Cerebrum) and antisense oligonucleotide (Solidus) platforms informed by human genetics and translational science.</parameter> <parameter name="founders">[]

3 investors

PraxisPro is an AI-powered learning platform designed for pharmaceutical and life sciences commercial teams, offering interactive roleplay scenarios, compliance training, and performance tracking tools for sales representatives, trainers, and compliance leaders.

3 investors

PreActiv offers a digital prehabilitation platform designed to help patients prepare for surgery, such as hip replacements, in order to reduce complications and shorten hospital stays. The product is aimed at surgical patients and healthcare providers seeking to improve post-operative recovery outcomes.

3 investors

Precision for Medicine is a contract research organization that provides clinical trial management and regulatory support for drug development programs, including oncology, hematology, cell and gene therapy, CAR-T, and radiopharmaceutical trials. It serves pharmaceutical and biotech sponsors running multinational Phase I–IV studies.

3 investors

Precision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.

3 investors

Prenetics is a health company that operates in genetic testing and precision diagnostics and runs the consumer health supplement brand IM8, sold direct-to-consumer and through Amazon and social commerce channels. The company markets longevity and wellness products globally, including partnerships with athletes and sports organizations.

3 investors

Prescrypto, based in Mexico, provides a platform for issuing and sending medical prescriptions electronically. It includes medicine catalogs with images, handles prescription records, and uses blockchain to create an auditable trail intended to limit diversion of controlled drugs. Physicians and clinics use it to generate, track, and review prescriptions from a single repository.

3 investors

Primary Record is a health information management platform that aggregates patient data from multiple portals and sources into a centralized location for families to organize, share, and access medical records.

3 investors

Primmune Therapeutics develops PRTX007, an orally administered, systemically active TLR7 agonist that activates interferon-associated innate immune pathways for use in cancer immunotherapy. The candidate is being developed for oncology applications, including combination with immune checkpoint inhibitors and neoadjuvant/adjuvant settings, and has been tested in two Phase 1 studies in healthy volunteers.

3 investors

Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation. Its work targets hematological malignancies such as acute myeloid leukemia, aiming to enhance the graft-versus-leukemia effect while reducing graft-versus-host disease.

3 investors

Privacy Analytics provides data anonymization technology, advisory services, and tailored solutions to help organizations safely combine, share, and reuse sensitive personal data while managing privacy risk and meeting regulatory requirements. It serves healthcare, life sciences, and enterprise customers.

3 investors

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.

3 investors

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue. The company's Lumee platform addresses oxygen monitoring for vascular surgery patients and continuous glucose monitoring for diabetes and prediabetes patients.

3 investors

3 investors

Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.

3 investors

Proof VC is a venture capital firm; this page presents its investment, operations, and venture team members rather than a portfolio company's product or service.

3 investors

ProQR develops medicines for patients with unmet medical needs, focusing on therapeutic development in biotech.

3 investors

Prosper provides AI agents to healthcare organizations to improve operational efficiency and patient access to care. The platform integrates with existing practice management and revenue cycle management systems to deliver scalable solutions with real-time analytics.

3 investors

Proven Skincare provides personalized skincare routines for acne-prone skin based on a science-backed quiz assessment. The company sells a three-step system directly to consumers.

3 investors

ProxiHealthcare develops bioelectric current technology to address microbial biofilm problems, backed by around 80 patents and global certifications. The company applies its patented approach at the intersection of medicine and engineering to create healthcare and oral care products.

3 investors

Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people. The company is also developing a dry blood spot biomarker test to distinguish Major Depressive Disorder from Bipolar disorder to reduce misdiagnosis.

3 investors